Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis

Figure 1

Construction and preparation of endostatin-lidamycin fusion proteins. Diagram of fusion proteins: LDP-ES (top) and ES-LDP (middle); Bottom, the amino acid sequence of the linker (A). (B) SDS-PAGE and (C) Western blotting detection of the expression of fusion proteins. Lane 1, molecular weight marker; Lane 2, empty vector as a control; Lane 3 and Lane 4, vector expressing LDP-ES; Lane 5 and Lane 6 vector expressing ES-LDP. Arrow indicates the bands of fusion proteins. The enediyne-energized fusion proteins determined by reverse-phase HPLC on C4 300A column at 340 nm (D).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us